We have received a lot of questions about the recent statement released by the DEA in regards to cannabinoid products. We know a lot of individuals who rely on these products to help improve their quality of life and overall health, and hope to help clarify the impact this action will have for our beloved clients.
First of all, we at RoC are not lawyers, and are still reviewing the "rule" with several leaders in the hemp and medicinal cannabis industries. From these collaborations and studying several legal opinions, we expect our product partners to go on with business as usual, allowing our clients to continue receiving the therapies they rely on.
If you have cause for concern, please refer to section 7606 of the 2014 US Farm Bill, which legally creates legitimacy of industrial hemp research, and defines industrial hemp as distinct from marijuana, authorizing institutions of higher education or state departments of agriculture (in states that legalized hemp cultivation) to conduct research and pilot programs across the country. In addition, the Omnibus Appropriations Act further solidifies this legal option, which is in place until April 2017.
If you're currently using a CBD-rich hemp extract and wish to participate in research, then guess what! You're in luck! Realm of Caring is partnered with Johns Hopkins University for this exact research (and more) and you can sign up here to participate! This participation may provide an additional layer of legal protection to those in states without medical programs. Keep in mind, this research only covers hemp products that are produced and approved in compliance with the Farm Bill.
We're happy, as always, to answer any questions to the best of our ability, so please continue to reach out with any concerns. If you have a question in regards to a certain product, please also reach out to that specific product's manufacturer.
Wishing everyone a wonderful holiday season, stay safe and warm!
-The Realm of Caring Team